Clinical Trial Search

Primary: Change in Glutamate Concentration During a Visual Stimulus Measured by fMRS at Normoxia — 4 percentage of concentration (micromol/g)

Primary: Measured Body Weight — 188.3; 187.7 lbs — p=>0.05

Primary: Cumulative Rates of Intraocular Pressure (IOP) Spikes 30mm of Mercury (mmHg) or Greater Measured Postoperatively — 17; 13 Participants

Primary: Number of Participants With Decline of Hepatitis Delta Virus (HDV) RNA Quantitative Measurements of >2 Logs From Baseline at 12 Weeks of Treatment — 1; 1; 1; 0…

Primary: Average Speed for 10 Meter Walk Test — 0.57; 0.53 m/s

Primary: Plasma PTH Level — 58.29; 60.73; 57.88; 54.05 pg/ml

Primary: The Number of Men Who Have Suppression of Sperm Production ≤1Million/mL Million/mL When Using a Daily Regimen of Nestorone® Gel (0, 8 or 12 mg) and Testosterone Gel…

Primary: NRS-Pain With Movement on POD 2 — 2.83 units on a scale

Primary: Number of Participants With Dose-limiting Toxicities (DLTs) at Phase 1B — 0; 0; 0; 0 Participants

Primary: Assessment of the Functionality of an Integrated Call Center for DMS by Adult Subjects With SCH, MDD, or BP1 Who Were Treated With Oral Aripiprazole. — 0; 0; 1; 8…

Primary: Feasibility of Recruitment, Measured by Number of Participants Recruited and Retained During Study Period — 24 Participants

Primary: Maximum Tolerated Dose (MTD) (Phase I) as Measured by the Number of Participants With Dose Limiting Toxicities — 0; 0; 1 Participants

Primary: Percentage of Participants With Primary Patency at 1 Year — 67.0; 49.5 Percentage of Participants

Primary: Number of Participants Experiencing Remission — 0; 2; 4; 2 Participants

Primary: Pre-school Language Test — 82.4 units on a scale